The first quarter did not live up to expectations at CVS Health, with earnings well short of Wall Street estimates and front-end comparable sales down. Company net income was $1.11 billion, or 88 cents per diluted share, versus $2.14 billion, or $1.65 per diluted...
In the first quarter, Rite Aid made strides, posting revenues that exceeded analyst expectations and a lower adjusted loss that also came in better than Wall Street anticipated. First quarter net loss was $306.7 million, or $5.56 per diluted share, compared to a net...
CVS beat Wall Street estimates in its fourth quarter while its front-end comparable sales made a strong gain after increasing 18.9% in the period a year past. Company net income was $2.3 billion, or $1.75 per diluted share, versus $1.31 billion, or 98 cents per...
The second quarter saw Rite Aid losses increase and sales come up short of last year’s period, although a bit ahead of Wall Street projections. For the quarter, the company reported a net loss of $331.3 million, or $6.07 per diluted share, versus a net loss of $100.3...
As the company continues on its reorganization as a community well resource, CVS Health beat Wall Street estimates on earnings and revenues while posting a strong comparable sales gain in the retail business. Company net income was $2.95 billion, or $2.23 per diluted...
